Cefotaxime resistance in bile samples is an independent predictor of deep infectious complications after pancreaticoduodenectomy in patients with endoprosthesis

ConclusionsThe incidence of DIC is high after pancreaticoduodenectomy, with or without endoprosthesis, despite routine postoperative treatment. Cefotaxime resistance, the only independent predictor of DIC in patients with endoprosthesis, has increased over time. Hence, cefotaxime may no longer be an appropriate empirical treatment.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - July 15, 2022 Category: Gastroenterology Authors: Fabien Robin, Marie Livin, Damien Bergeat, Haitham Triki, Elodie Gaignard, Marine Cailleaux, Vincent Cattoir, Karim Boudjema, Pierre Tattevin, Laurent Sulpice Tags: ORIGINAL ARTICLE Source Type: research